Presentations and Posters
2010
A multicenter, randomized phase II study of neoadjuvant chemotherapy including trastuzumab with cyclophosphamide with docetaxel in patients with operable HER2-positive breast cancer (JBCRG-10 study).
増田慎三、戸井雅和、上野貴之、青儀健二郎、岩田広治、大野真司、黒井克昌、佐藤信昭、中村清吾; Japan Breast Cancer Research Group (JBCRG)
2010 American Society of Clinical Oncology, Chicago (USA), Jun. 2010
by Voluntary Organization JBCRG